SCHEMBL7923353

SCHEMBL7923353

CCCCCC(C=NO)CCCCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
OPRM1 P35372 1/20 0.37
FDPS P14324 4/20 0.37
MAPT P10636 2/20 0.36
TRPA1 O75762 1/20 0.36
DDAH1 O94760 1/20 0.36
GAPDH P04406 1/20 0.36
GPR84 Q9NQS5 3/20 0.35
SPHK1 Q9NYA1 1/20 0.35
FFAR1 O14842 1/20 0.35
CA1 P00915 1/20 0.35
TP53 P04637 1/20 0.34
LAP3 P28838 1/20 0.34
EP300 Q09472 1/20 0.34
LCK P06239 1/20 0.34
PPARD Q03181 1/20 0.34
ZDHHC20 Q5W0Z9 1/20 0.34
ZDHHC2 Q9UIJ5 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7923350 1.00 LMNA (0.39) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL20143287 0.98 LMNA (0.43) LMNATSHRSMN1; SMN2FDPSMAPT
SCHEMBL20143282 0.98 LMNA (0.43) LMNATSHRSMN1; SMN2FDPSMAPT
SCHEMBL28690695 0.93 TSHR (0.44) LMNATSHRSMN1; SMN2FDPSCA1
SCHEMBL8601150 0.91 TSHR (0.45) LMNATSHRSMN1; SMN2OPRM1FDPS
SCHEMBL8182070 0.88 TSHR (0.41) TSHRSMN1; SMN2FDPSCA1
SCHEMBL28753432 0.87 SPHK1 (0.40) LMNAOPRM1MAPTGPR84SPHK1
SCHEMBL8902146 0.84 TSHR (0.52) TSHRSMN1; SMN2FDPSCA1
SCHEMBL8902150 0.84 TSHR (0.52) TSHRSMN1; SMN2FDPSCA1
SCHEMBL28181292 0.82 TSHR (0.50) TSHRSMN1; SMN2FDPSCA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6174898-B1 TREATING FILARIAE IN LYMPHATIC SYSTEM BY ADMINISTERING N-SUBSTITUTED AZAHETEROCYCLIC CARBOXYLIC ACIDS AND ESTERS IN WHICH A SUBSTITUTED ALKYL CHAIN FORMS PART OF N-SUBSTITUENT AND SALTS NOVO NORDISK A/S (DK) 2001-01-16 US disclosed
EP-0858339-A1 A METHOD OF TREATING FILARIAE NOVO NORDISK A/S (DK) 1998-08-19 EP disclosed
WO-1997017073-A1 A METHOD OF TREATING FILARIAE NOVO NORDISK A/S (DK) 1997-05-15 WO disclosed
EP-0342635-B1 Azacyclic carboxylic acid derivatives, their preparation and use NOVO NORDISK AS (DK) 1994-08-17 EP disclosed
US-5231106-A Nervous sytem disorders; blocking og gamma aminobutyric acid NOVO NORDISK A/S (DK) 1993-07-27 US disclosed
US-5229404-A Inhibitors of gamma-aminobutyric acid re-uptake, antiepileptic agents NOVO NORDISK A/S (DK) 1993-07-20 US disclosed
US-5214054-A Gamma-aminobutyric acid re-uptake inhibitors, antiepileptic, analgesics, anxiolytics NOVO NORDISK A/S (DK) 1993-05-25 US disclosed
CN-1018829-B PROCESS FOR THE PREPARATION OF NOVEL ALKYLENEDIAMINE DERIVATIVES NIPPON CHEMIPHAR CO (JP) 1992-10-28 CN disclosed
US-5039685-A Nervous system disorders NOVO NORDISK A/S (DK) 1991-08-13 US disclosed
EP-0342635-A1 Azacyclic carboxylic acid derivatives, their preparation and use NOVO NORDISK A/S (DK) 1989-11-23 EP disclosed
CN-87101762-A The method for preparing novel alkylenediamine derivatives 1987-10-07 CN disclosed